|
ACAA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.95220000001706E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.000330E-04 |
| Normal-vs-Stage2 |
4.360700E-04 |
| Normal-vs-Stage3 |
5.44669999991143E-07 |
| Normal-vs-Stage4 |
1.86019977199692E-10 |
| Stage1-vs-Stage2 |
6.256600E-01 |
| Stage1-vs-Stage3 |
9.956300E-02 |
| Stage1-vs-Stage4 |
2.15959999999571E-05 |
| Stage2-vs-Stage3 |
3.881200E-01 |
| Stage2-vs-Stage4 |
1.465790E-02 |
| Stage3-vs-Stage4 |
4.602000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.51763999999277E-05 |
| Normal-vs-AfricanAmerican |
2.86949999983577E-07 |
| Normal-vs-Asian |
1.760950E-03 |
| Caucasian-vs-AfricanAmerican |
3.359600E-01 |
| Caucasian-vs-Asian |
3.450600E-01 |
| AfricanAmerican-vs-Asian |
4.927000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73390000024476E-07 |
| Normal-vs-Female |
4.4162999999986E-05 |
| Male-vs-Female |
7.673200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.000390E-04 |
| Normal-vs-Extreme_Weight |
4.85480000644856E-09 |
| Normal-vs-Obese |
1.22589999995704E-06 |
| Normal-vs-Extreme_Obese |
6.044200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.299600E-01 |
| Normal_Weight-vs-Obese |
7.223400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.273830E-01 |
| Extreme_Weight-vs-Obese |
5.754200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.360020E-01 |
| Obese-vs-Extreme_Obese |
1.777600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.612800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.57516000000024E-05 |
| Normal-vs-Age(61-80Yrs) |
1.1311000003289E-07 |
| Normal-vs-Age(81-100Yrs) |
4.465900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.224400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.933200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.471000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.987600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.052800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.817600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.12940000474416E-08 |
| Normal-VS-Type2 PRCC |
2.699300E-03 |
| Normal-VS-KIRP CIMP |
3.31760000027437E-07 |
| Normal-VS-Unclassified PRCC |
2.09120000205232E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.117000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.124200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.159800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.801680E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.827750E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.040000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.022900E-04 |
| Normal-vs-N1 |
4.54280002504248E-09 |
| Normal-vs-N2 |
6.50146603220492E-12 |
| N0-vs-N1 |
7.062400E-03 |
| N0-vs-N2 |
2.60530000018022E-07 |
| N1-vs-N2 |
7.018500E-02 |
|
|
